Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA. by Rachael M. Giersch (22331947)

Subjects:

Data for Fig 1. by Rachael M. Giersch (22331947)

Subjects:

Changepoint analysis in comparison of MarBTN-specific eDNA and cancer in hemolymph. by Rachael M. Giersch (22331947)

Subjects:

Survival of soft-shell clams with MarBTN compared to control clams. by Rachael M. Giersch (22331947)

Subjects:

Analysis of TA system gene expression with or without (control) D29 infection for 2h by qRT-PCR. by Fatema Calcuttawala (8399577)

This is the raw data used for this study. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Patient Demographics. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

The human neutrophil IL-1β secretory response, in contrast to the CXCL8/IL-8 secretory response decreases as MOI increases. by Florencia Sabbione (4862455)

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

Scatter dot plot of the absolute levels of change in LH and FSH between the baseline and week-15 visit. by Sigrid Nilsson (12647302)

EHD2 siRNA treated HUVEC showed decreased NO generation and cytosolic Ca²⁺ response. by Claudia Matthaeus (7485782)

Kcnk5b activity induces IP₃R-mediated Ca²⁺ release from the ER. by Xiaowen Jiang (8291814)

Comparison of cell cytotoxicity effect. by Alireza Latifi (14593561)

Early IOP lowering response following injection with ssAAV2-STC-1-FLAG. by Gavin W. Roddy (7320446)

Establishment of a diabetic rat model. by Lan Zeng (638254)

“…In addition, RP11-502I4.3 expression was decreased in the retinas of diabetic rats compared with non-diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3B</a>), and it was predominantly localised in the cytoplasm (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3C</a>).…”

Table7_Non-target screening to track contaminant removal and release during nature-based water treatment.xlsx by Charlotte Guy (18392850)

“…</p><p>Results: Differential analysis shows significant differences in compounds that decrease or increase after contact with BR. …”

Table6_Non-target screening to track contaminant removal and release during nature-based water treatment.xlsx by Charlotte Guy (18392850)

“…</p><p>Results: Differential analysis shows significant differences in compounds that decrease or increase after contact with BR. …”